Movement Alert｜GE HEALTHCARE TECHNOLOGIES INC Rises 7.46% in Regular Trading, Q2 Earnings Beat Expectations with Full-Year Guidance Reaffirmed

Market Focus

Jul 29

On July 29, GE HEALTHCARE TECHNOLOGIES INC rose 7.46% in regular trading, trading at $68.9/share, with turnover of $66.528 million.

The rally was driven by the company's Q2 earnings release, which showed adjusted EPS of $1.13, significantly exceeding the consensus estimate of $1.04, with net income reaching $561 million. Simultaneously, the company reaffirmed its full-year adjusted EPS guidance range of $4.80 to $5.00, aligning with the FactSet consensus estimate of $4.88.

This reaffirmation carries particular significance as the company had previously lowered its full-year EPS guidance from $4.95-$5.15 during Q1 due to surging memory chip, oil, and freight costs. The maintained outlook signals that cost pressures have been effectively managed. Additionally, management indicated that Patient Care Solutions segment supply conditions are expected to improve in the second half, which should benefit both sales and margins. The company also highlighted its strategic focus on artificial intelligence to enhance productivity and strengthen supply chain resilience.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1177411618"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1177411618\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1177411618?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-29 21:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1177411618","market":"us","top_or_hot":-1,"title":"Movement Alert｜GE HEALTHCARE TECHNOLOGIES INC Rises 7.46% in Regular Trading, Q2 Earnings Beat Expectations with Full-Year Guidance Reaffirmed","media":"Market Focus","content":"<p><p>On July 29, GE HEALTHCARE TECHNOLOGIES INC rose 7.46% in regular trading, trading at $68.9/share, with turnover of $66.528 million.</p><p>The rally was driven by the company's Q2 earnings release, which showed adjusted EPS of $1.13, significantly exceeding the consensus estimate of $1.04, with net income reaching $561 million. Simultaneously, the company reaffirmed its full-year adjusted EPS guidance range of $4.80 to $5.00, aligning with the FactSet consensus estimate of $4.88.</p><p>This reaffirmation carries particular significance as the company had previously lowered its full-year EPS guidance from $4.95-$5.15 during Q1 due to surging memory chip, oil, and freight costs. The maintained outlook signals that cost pressures have been effectively managed. Additionally, management indicated that Patient Care Solutions segment supply conditions are expected to improve in the second half, which should benefit both sales and margins. The company also highlighted its strategic focus on artificial intelligence to enhance productivity and strengthen supply chain resilience.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜GE HEALTHCARE TECHNOLOGIES INC Rises 7.46% in Regular Trading, Q2 Earnings Beat Expectations with Full-Year Guidance Reaffirmed</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜GE HEALTHCARE TECHNOLOGIES INC Rises 7.46% in Regular Trading, Q2 Earnings Beat Expectations with Full-Year Guidance Reaffirmed\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-29 21:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 29, GE HEALTHCARE TECHNOLOGIES INC rose 7.46% in regular trading, trading at $68.9/share, with turnover of $66.528 million.</p><p>The rally was driven by the company's Q2 earnings release, which showed adjusted EPS of $1.13, significantly exceeding the consensus estimate of $1.04, with net income reaching $561 million. Simultaneously, the company reaffirmed its full-year adjusted EPS guidance range of $4.80 to $5.00, aligning with the FactSet consensus estimate of $4.88.</p><p>This reaffirmation carries particular significance as the company had previously lowered its full-year EPS guidance from $4.95-$5.15 during Q1 due to surging memory chip, oil, and freight costs. The maintained outlook signals that cost pressures have been effectively managed. Additionally, management indicated that Patient Care Solutions segment supply conditions are expected to improve in the second half, which should benefit both sales and margins. The company also highlighted its strategic focus on artificial intelligence to enhance productivity and strengthen supply chain resilience.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"GEHC","symbol_name":"GE HEALTHCARE TECHNOLOGIES INC","start_time":0,"source_url":"","article_id":"1177411618","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1177411618","pubTimestamp":1785331937,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 29, GE HEALTHCARE TECHNOLOGIES INC rose 7.46% in regular trading, trading at $68.9/share, with turnover of $66.528 million.The rally was driven by the company's Q2 earnings release, which...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"GEHC":"GE HEALTHCARE TECHNOLOGIES INC"},"translate_title":"走势警报|GE HEALTHCARE TECHNOLOGIES INC 常规交易中上涨 7.46%，第二季度盈利超出预期，全年指引重申","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GEHC":1},"content_text":"On July 29, GE HEALTHCARE TECHNOLOGIES INC rose 7.46% in regular trading, trading at $68.9/share, with turnover of $66.528 million.The rally was driven by the company's Q2 earnings release, which showed adjusted EPS of $1.13, significantly exceeding the consensus estimate of $1.04, with net income reaching $561 million. Simultaneously, the company reaffirmed its full-year adjusted EPS guidance range of $4.80 to $5.00, aligning with the FactSet consensus estimate of $4.88.This reaffirmation carries particular significance as the company had previously lowered its full-year EPS guidance from $4.95-$5.15 during Q1 due to surging memory chip, oil, and freight costs. The maintained outlook signals that cost pressures have been effectively managed. Additionally, management indicated that Patient Care Solutions segment supply conditions are expected to improve in the second half, which should benefit both sales and margins. The company also highlighted its strategic focus on artificial intelligence to enhance productivity and strengthen supply chain resilience.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}